Saturday 17 October 2026
Export NVNO’s income statement to Excel — free account
enVVeno Medical Corporation
NVNO Healthcare Medical Devices
In the quarter to June 2026, EPS grew 53.6% and free cash flow grew 4.60%, each against the same quarter a year earlier.
7.47
0.46
−5.80%
Follow NVNO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(57.19%) | (56.21%) | (60.65%) | (58.53%) | |
| (53.09%) | (52.26%) | (56.45%) | (53.09%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(75.27%) | (72.78%) | (80.55%) | (77.56%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(30.03) | (26.45) | (22.61) | (21.79) | |
Free Cash Flow |
(17.25) | (15.58) | (14.79) | (14.62) | |
Capital Expenditures |
(0.02) | (0.01) | — | — | |
| Other line items | |||||
Cash ROIC |
(28.56%) | (28.15%) | (30.38%) | (34.69%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
0.78 | 0.80 | 0.79 | 0.93 | |
Depreciation/Fixed assets |
6.02 | 9.59 | 30.69 | 5.00 | |
Capex/Depreciation |
(0.04) | (0.02) | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(30.00) | (26.43) | (22.61) | (21.79) | |
Capex per Share |
(0.03) | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | — | — |
Columns are period end dates